Development of a Prognostic Model for MACE in Atherosclerosis Based on MTHFR and Serum Markers
Background and Aims Atherosclerosis (AS) is associated with high residual cardiovascular risk despite standard treatment. Abnormal homocysteine metabolism and MTHFR polymorphisms are involved in AS progression, but few prognostic models integrate genetic and multidimensional biochemical indicators. This study aimed to...